PuraPharm Corporation Limited

PuraPharm Corporation Limited - PE Ratioverified

1498.HK

Price:

$0.241

Market Cap:

$128.95M

PuraPharm Corporation Limited, an investment holding entity, focuses on the research, development, manufacturing, and global distribution of concentrated Chinese medicine granules (CCMG) and various Chinese healthcare products across Hong Kong, Mainland China, and international markets. Its operations are structured into five key divisions: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers a range of over-the-counter health solutions under brand names such as PuraGold, Haveron, Oncozac, and Immuzac. Beyond product sales, PuraPharm provides a clinic management system for general Chinese medical practices and operates its own chain of Nong's C...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-07-08

Stock Exchange

HKSE

Ticker

1498.HK

The PE Ratio as of October 2026 (TTM) for PuraPharm Corporation Limited (1498.HK) is -4.24

According to PuraPharm Corporation Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.24. This represents a change of 51.92% compared to the average of -2.79 of the last 4 quarters.

PuraPharm Corporation Limited (1498.HK) Historical PE Ratio (quarterly & annually)

How has 1498.HK PE Ratio performed in the past?

The mean historical PE Ratio of PuraPharm Corporation Limited over the last ten years is 41.27. The current -4.24 PE Ratio has changed -1127.27% with respect to the historical average. Over the past ten years (40 quarters), 1498.HK's PE Ratio was at its highest in in the June 2017 quarter at 22.06. The PE Ratio was at its lowest in in the December 2017 quarter at -24.96.

Quarterly (TTM)
Annual

Average

41.27

Median

-2.04

Minimum

-6.13

Maximum

376.58

PuraPharm Corporation Limited (1498.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PuraPharm Corporation Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.31%

Maximum Annual PE Ratio = 376.58

Minimum Annual Increase = -639.47%

Minimum Annual PE Ratio = -6.13

Quarterly (TTM)
Annual
YearPE RatioChange
2025-4.22-31.16%
2024-6.1386.01%
2023-3.30-22.74%
2022-4.2763.29%
2021-2.61-132.85%
20207.95-639.47%
2019-1.47-106.27%
201823.50-93.76%
2017376.581.31%
201626.71-1.79%

PuraPharm Corporation Limited (1498.HK) Average PE Ratio

How has 1498.HK PE Ratio performed in the past?

The current PE Ratio of PuraPharm Corporation Limited (1498.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-4.55

5-year avg

-4.11

10-year avg

41.27

PuraPharm Corporation Limited (1498.HK) PE Ratio vs. Peers

How is 1498.HK’s PE Ratio compared to its peers?

PuraPharm Corporation Limited’s PE Ratio is less than King International Investment Limited (75.91), greater than Kelfred Holdings Limited (-4.34), less than Universal Health International Group Holding Limited (-2.23), less than China Health Group Inc. (-3.14), greater than Regent Pacific Group Limited (-15.88), less than Extrawell Pharmaceutical Holdings Limited (-0.19), less than China Regenerative Medicine International Limited (3.16), greater than Tianda Pharmaceuticals Limited (-6.14), less than China Healthwise Holdings Ltd. (-1.70), less than Qianhai Health Holdings Limited (15.19),

Build a custom stock screener for PuraPharm Corporation Limited (1498.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PuraPharm Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PuraPharm Corporation Limited (1498.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PuraPharm Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is PuraPharm Corporation Limited's PE Ratio?

How is the PE Ratio calculated for PuraPharm Corporation Limited (1498.HK)?

What is the highest PE Ratio for PuraPharm Corporation Limited (1498.HK)?

What is the 3-year average PE Ratio for PuraPharm Corporation Limited (1498.HK)?

What is the 5-year average PE Ratio for PuraPharm Corporation Limited (1498.HK)?

How does the current PE Ratio for PuraPharm Corporation Limited (1498.HK) compare to its historical average?